Stockscreener 앱 받기
28.24
0.38%
0.11
전일 마감가:
$28.13
열려 있는:
$28.29
하루 거래량:
191.73K
Relative Volume:
0.32
시가총액:
$1.32B
수익:
$1.08B
순이익/손실:
$-20.76M
주가수익비율:
-61.39
EPS:
-0.46
순현금흐름:
$151.63M
1주 성능:
+5.05%
1개월 성능:
-1.75%
6개월 성능:
-35.28%
1년 성능:
-3.59%
1일 변동 폭
$27.77
$28.30
1주일 범위
$27.01
$29.02
52주 변동 폭
$22.66
$55.74
옴니셀 Stock (OMCL) Company Profile
명칭
Omnicell Inc
전화
(877) 415-9990
주소
4220 NORTH FREEWAY, FORT WORTH
OMCL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
28.23 | 1.32B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
290.57 | 46.74B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
63.68 | 11.23B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
60.44 | 11.43B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
96.39 | 8.38B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.24 | 6.39B | 906.14M | -52.62M | 89.62M | -0.3621 |
옴니셀 Stock (OMCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 개시 | Barclays | Underweight |
| 2023-11-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 재확인 | Wells Fargo | Underweight |
| 2023-08-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-11-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 개시 | BofA Securities | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Mkt Perform |
| 2021-12-06 | 재개 | Wells Fargo | Overweight |
| 2021-06-09 | 개시 | JP Morgan | Neutral |
| 2021-05-24 | 개시 | BTIG Research | Buy |
| 2021-02-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-12-03 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-02-07 | 재확인 | Dougherty & Company | Buy |
| 2019-11-21 | 재확인 | Dougherty & Company | Buy |
| 2019-07-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-03-07 | 재확인 | Dougherty & Company | Buy |
| 2018-06-29 | 재개 | The Benchmark Company | Buy |
| 2017-09-05 | 재확인 | The Benchmark Company | Buy |
| 2017-07-28 | 재확인 | Dougherty & Company | Buy |
| 2017-04-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 개시 | Dougherty & Company | Buy |
| 2016-12-06 | 재확인 | The Benchmark Company | Buy |
| 2016-07-07 | 재확인 | FBR Capital | Outperform |
| 2016-03-21 | 재확인 | Topeka Capital Markets | Buy |
| 2016-01-07 | 개시 | The Benchmark Company | Buy |
| 2015-11-16 | 재확인 | Topeka Capital Markets | Buy |
| 2015-10-30 | 재확인 | FBR Capital | Outperform |
| 2015-09-28 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-07-31 | 재확인 | Topeka Capital Markets | Buy |
모두보기
옴니셀 주식(OMCL)의 최신 뉴스
Why Omnicell Inc. stock is on top investor watchlistsUnprecedented profits - jammulinksnews.com
Should I buy Omnicell Inc. stock before earningsMarket-beating returns - jammulinksnews.com
How Omnicell Inc. stock reacts to Fed policy changesRapid market gains - jammulinksnews.com
Omnicell Inc. Stock Analysis and ForecastFree Investment Risk Control - Autocar Professional
Pharmacy Automation Market Booming with Smart Dispensing - openPR.com
Omnicell's Path to Resilience: Navigating Short-Term Headwinds to Unlock Long-Term Value - AInvest
Analysts Estimate Omnicell (OMCL) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
3 Healthcare Stocks We Approach with Caution - FinancialContent
What drives Omnicell Inc. stock priceRobust investment performance - jammulinksnews.com
Is Omnicell Inc. a good long term investmentOutstanding trading profits - jammulinksnews.com
What analysts say about Omnicell Inc. stockExplosive returns - jammulinksnews.com
Robotic Pharmacy Automation System Market Set to Witness - openPR.com
Why Omnicell (OMCL) Stock Is Trading Up Today - TradingView
Pharmacy Automation Market Surges with 10.12% CAGR; AI & Retail Pharmacy Demand Transform Dispensing in 2025 - GlobeNewswire Inc.
Omnicell price target raised to $40 from $37 at Wells Fargo - TipRanks
Wells Fargo raises Omnicell stock price target to $40 on reduced tariff impact - Investing.com Canada
Published on: 2025-07-18 21:34:02 - jammulinksnews.com
Benchmark reiterates Buy rating on Omnicell stock amid tariff uncertainties By Investing.com - Investing.com Canada
Adherence Packaging Market to Witness Massive Growth by CAGR - openPR.com
Omnicell (NASDAQ:OMCL) Could Be Struggling To Allocate Capital - Yahoo Finance
Unexpected Trends Reshaping the Central Fill Pharmacy - openPR.com
Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025 - BioSpace
Omnicell's Q2 Outlook: Autonomous Pharmacy Momentum and Undervalued Growth Catalysts - AInvest
Omnicell's Growth Uncertainty Amidst Market Challenges: A Hold Rating Analysis - AInvest
Omnicell to Release Second Quarter 2025 Financial Results on Jul - GuruFocus
Omnicell (OMCL) Faces Target Price Adjustment Amid Revenue Uncer - GuruFocus
A Hidden Reason Omnicell's Future Looks Bright - AOL.com
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
Markets | American Financial Group, Inc. - FinancialContent
Medication Management System Market Set to Witness Significant - openPR.com
Omnicell stock maintains Buy rating at Craig-Hallum amid tariff adjustments - Investing.com Canada
3 Reasons to Sell OMCL and 1 Stock to Buy Instead - Yahoo Finance
Automated Medication Compounding System Market Generated - openPR.com
Q1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers Stocks - Yahoo Finance
Pharmacy Automation Devices Market Set to Witness Significant - openPR.com
Learn to Evaluate (OMCL) using the Charts - news.stocktradersdaily.com
옴니셀 (OMCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
옴니셀 주식 (OMCL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
0.19%
1.18%
자본화:
|
볼륨(24시간):